Pam Stetkiewicz is the Chief Operating Officer at Arbor Biotechnologies, a biotech executive with over 20 years of experience in drug development. She specializes in small molecules, biotherapeutics, and gene therapy, holding a PhD from The Johns Hopkins University. She is also a board member at Genezen and ImmuneID.
Outside of work, Pam enjoys spending time with her husband and two sons, relaxing at the beach, and is an avid golfer. She is passionate about building strong company cultures and is inspired by the resiliency of the rare disease community.
A key highlight of her career was leading the team that filed the first-ever IND for an in vivo CRISPR therapeutic while at Editas Medicine.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.